Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

iwNHL 2019 Session V: Novel Lymphoma Targets/Agents

Oral PI3K-δ and PI3K-γ inhibitors in lymphoma

Sven de Vos